APPLICATION
NDA017569
TYPE
NDA
ORIGINAL APPROVAL
1975-09-12
LATEST ACTION
1986-12-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
RENOQUIDDiscontinued
SULFACYTINE 250MG · TABLET · ORAL
Approval history
1986-12-16Labeling · Supplement 6 · priorityAP
1981-04-09Manufacturing (CMC) · Supplement 5 · priorityAP
1979-10-23Manufacturing (CMC) · Supplement 4 · priorityAP
1978-07-05Manufacturing (CMC) · Supplement 3 · priorityAP
1978-01-12Manufacturing (CMC) · Supplement 2 · priorityAP
1976-11-22Manufacturing (CMC) · Supplement 1 · priorityAP
1975-09-12Type 1 - New Molecular Entity · Original · priorityAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.